IPCALAB Outperforms Weak Market, Records Sixth Consecutive Up Day

As on 9 Jan 2026, Ipca Laboratories (

) continued to outperform the broader market, marking its sixth consecutive winning session. The stock gained over 2% on Friday and traded at its highest level since 28 July 2025, highlighting strengthening momentum. On a weekly basis, IPCALAB surged around 12% for the week ending 9 January 2026, even as overall market sentiment remained subdued. The sustained upward move suggests consistent buying interest across recent sessions. Price action over the past week has been decisively positive, with higher highs and higher closes indicating improving near-term strength. The stock’s relative outperformance against a weak market backdrop has kept it firmly on traders’ and investors’ watchlists. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.